Market Access What the low impact of Humira biosimilars teaches us about d... Almost everyone seems to agree that drug prices are too high.
R&D CSL reflects on its future, past as new R&D lab opens Last month, global pharmaceutical maker CSL cut the ribbon on a brand-new research facility in Waltham, Massachusetts, wher
Patients Adhering to core principles when delivering humanitarian aid Humanity, Impartiality, Neutrality, and Independence – the core principles identified as necessary to effective humanitarian response.
Patients Will EU patients get the right treatment after legislation? The EU’s proposal for a revision of the general pharmaceutical legislation aims to ensure EU citizens have access to affordable medicines and that unmet medical needs are addressed – all wh
Patients Challenges and opportunities with plasma-derived therapies This newest pharmaphorum podcast welcomes Takeda's Dr Kristina Allikmets.
Patients Tech to make healthcare more accessible for Latinx patients How emerging technology could make healthcare more accessible for Spanish-speaking communities.
News Astellas pays $285m for Audax cancer drug, and other deals Astellas takes an option on a cancer immunotherapy developed by Audax for up to $1.34bn, with Gilead and Teva also adding to their pipelines.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
